Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 66.05
+0.30 (0.46%)
Jul 24, 2026, 5:35 PM CET
Redcare Pharmacy NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,073 | 2,941 | 2,371 | 1,799 | 1,204 | 1,060 | |
Revenue Growth (YoY) | 21.58% | 24.06% | 31.79% | 49.35% | 13.58% | 9.53% |
Cost of Revenue | 2,399 | 2,278 | 1,825 | 1,358 | 872.57 | 793.79 |
Gross Profit | 673.8 | 663.1 | 545.8 | 440.38 | 331.79 | 266.53 |
Selling, General & Admin | 697.1 | 692.1 | 585.1 | 458 | 401.11 | 332.39 |
Other Operating Expenses | -0.28 | -0.5 | -0.3 | -0.32 | -0.15 | -0.16 |
Total Operating Expenses | 696.82 | 691.6 | 584.8 | 457.68 | 400.96 | 332.23 |
Operating Income | -23.02 | -28.5 | -39 | -17.3 | -69.17 | -65.7 |
Interest Income | 10.86 | 11.7 | 7.4 | 18.22 | 2.08 | 1.52 |
Interest Expense | -33.9 | -31.3 | -16.7 | -15.5 | -17.36 | -13.28 |
Other Non-Operating Income (Expense) | 0.78 | 0.4 | 0.4 | 0.23 | 0.34 | -0.43 |
Total Non-Operating Income (Expense) | -22.27 | -19.2 | -8.9 | 2.95 | -14.95 | -12.19 |
Pretax Income | -45.3 | -47.7 | -47.9 | -14.35 | -84.12 | -77.88 |
Provision for Income Taxes | -6.54 | -8.3 | -1.5 | -2.74 | -6.47 | -3.7 |
Net Income | -38.8 | -39.4 | -46.4 | -11.61 | -77.65 | -74.19 |
Minority Interest in Earnings | -1.4 | -1.7 | -0.9 | 0.44 | 0 | - |
Net Income to Common | -37.4 | -37.7 | -45.5 | -12.04 | -77.65 | -74.19 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 20 | 20 | 19 | 18 | 18 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 19 | 18 | 18 |
Shares Change (YoY) | 1.73% | 0.27% | 4.24% | 6.97% | 0.57% | 24.37% |
EPS (Basic) | -1.83 | -1.87 | -2.27 | -0.73 | -4.32 | -4.15 |
EPS (Diluted) | -1.83 | -1.87 | -2.27 | -0.73 | -4.32 | -4.15 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -63 | -48.3 | 13.4 | 55.02 | -42.68 | -2.18 |
Free Cash Flow Growth | - | - | -75.64% | - | - | - |
Free Cash Flow Per Share | -3.09 | -2.40 | 0.67 | 2.86 | -2.37 | -0.12 |
Gross Margin | 21.93% | 22.55% | 23.02% | 24.48% | 27.55% | 25.14% |
Operating Margin | -0.75% | -0.97% | -1.65% | -0.96% | -5.74% | -6.20% |
Profit Margin | -1.26% | -1.34% | -1.96% | -0.65% | -6.45% | -7.00% |
FCF Margin | -2.05% | -1.64% | 0.57% | 3.06% | -3.54% | -0.21% |
EBITDA | 53.08 | 47.4 | 29.2 | 39.99 | -29.66 | -38.73 |
EBITDA Margin | 1.73% | 1.61% | 1.23% | 2.22% | -2.46% | -3.65% |
EBIT | -23.02 | -28.5 | -39 | -17.3 | -69.17 | -65.7 |
EBIT Margin | -0.75% | -0.97% | -1.65% | -0.96% | -5.74% | -6.20% |
Effective Tax Rate | 14.43% | 17.40% | 3.13% | 19.11% | 7.70% | 4.75% |